Status report
Get it in writing
The official USPTO status record for STICK IT TO MELANOMA, serial 90571668, as a dated PDF. One price, one document, delivered in about a minute.
INSTANT DELIVERY
Trademark Status Report
$7.99
The USPTO's own status record for this mark, on one dated page.
- Current status with a plain-English verdict
- Owner, classes, filing basis, and every key date
- The mark as it appears on the federal record
- Every prosecution event, filing to today
- Source-cited with the exact retrieval date
Built from the USPTO's TSDR record. Assignment chain of title and TTAB proceeding files sit in separate USPTO systems and are not included.
Preview
◆ TRADEMARKCHECKER.AITRADEMARK STATUS REPORT
STICK IT TO MELANOMASerial 90571668 · Principal Register
Dead · Refused
Owner: DermTech, Inc.
Class 010 -
Filed Mar 10, 2021
The record shows that the mark “STICK IT TO MELANOMA” is dead, having been abandoned by DermTech, Inc., a Delaware corporation, after the owner failed to file a Statement of Use or Extension Request following the Notice of Allowance issued on January 11, 2022. The mark was registered on the Principal Register for class 010 goods, specifically a skin sample collection kit made of adhesive patches that collect skin cells for genetic or protein analysis to assess skin disorder risk. A similar name would raise the closest concern for products or services that involve adhesive skin patches or skin sample kits. The record does not give the owner control over every use of the wording, only over the specified goods. No enforcement activity—oppositions, cancellations, or court actions—is visible in the supplied history. The last meaningful event was the abandonment notice on August 15, 2022. For someone considering a similar name, the primary risk lies in the specific adhesive skin‑sample kit market; other unrelated uses may be farther from the record’s scope.
Full event history, owner details, and verdict inside.
The way I'd use it, honestly, is as the thing you attach when a bank, a marketplace, or a co-founder asks "are we clear on the name". It answers in one page.